✦ LIBER ✦

P169 - Higher remission rates in patients with once-daily dosing compared to twice-daily dosing. An analysis of compliance in the once daily vs. twice daily podium trial with mesalazine (Pentasa®) sachets

✍ Scribed by B. Bokemeyer; A. Dignass; T. Stijnen; H. Veerman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P158 - Safety of once daily versus twice

✍ A. Dignass; B. Bokemeyer; T. Stijnen; H. Veerman 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 48 KB

P353 The economics of 4 grams once daily

✍ Connolly, M.; Kuyvenhoven, J.; Postma, M.; Nielsen, S. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 49 KB

T1146 Maintenance Therapy with Once-Dail

✍ Dignass, Axel U.; Bokemeyer, Bernd; Adamek, H.E.; Mross, Michael R.; Vinter-Jens 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 89 KB

P055 MAINTENANCE THERAPY WITH ONCE-DAILY

✍ A. Dignass; M. Mross; T. Klugmann; P. Dietel; H. Adamek; N. Börner; B. Bokemeyer 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 66 KB

P138 MAINTENANCE OF REMISSION IN PATIENT

✍ S. Schreiber; K. Barrett; K. Lees; R. Joseph 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 96 KB